In 2025, COVID-19 symptoms resemble a bad cold, with XFG (Stratus) as the dominant variant. Updated vaccines target KP.2 and JN.1, preventing severe illness. Treatments like Paxlovid remain effective for high-risk groups, and long COVID still affects 20% of survivors.
Combining SSRIs with anticoagulants increases bleeding risk by 33%, especially in the first 30 days. Learn why, where bleeding occurs, which drugs are riskiest, and how to stay safe.
PDE5 inhibitors like Viagra and Cialis can cause life-threatening low blood pressure when mixed with nitrates. Learn how the interaction works, how long to wait between doses, and what to do in an emergency.
C. diff colitis is a serious infection triggered by antibiotics, causing severe diarrhea and recurring illness. Fecal transplant offers up to 94% cure rates for recurrent cases, restoring gut health where antibiotics fail.
Prediabetes often has no symptoms, but early signs like increased thirst, fatigue, and dark skin patches can signal insulin resistance. With simple lifestyle changes-weight loss, movement, and better food-you can reverse it before it becomes type 2 diabetes.
Learn how DMARDs and biologics work together to treat rheumatoid arthritis, the real-world challenges of cost and side effects, and why methotrexate remains the foundation of treatment despite newer, pricier options.
Placebo and nocebo effects shape how patients experience medication side effects - even when no active drug is present. Studies show nocebo effects are stronger, longer-lasting, and responsible for up to 76% of reported side effects in trials.
Social media is transforming patient education by making health information more accessible, visual, and relatable. From TikTok diabetes tips to Instagram recovery guides, digital platforms help patients understand conditions, manage meds, and feel supported-before they even see a doctor.
GLP-1 receptor agonists like Ozempic and Wegovy help lower A1C and promote significant weight loss by reducing appetite and slowing digestion. Learn how they work, their real-world results, side effects, cost, and long-term use.
Treat-to-target strategies for rheumatoid arthritis use objective measures like DAS28 to guide treatment toward remission or low disease activity. Proven in clinical trials, this approach significantly improves outcomes compared to traditional care.